Dan Shilo

Dan Shilo

Auto-generated profile, based on publicly available information

Dan Shilo

Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 May 2025 in Journal of Vascular and Interventional Radiology
Verified
Journal Article
Closed access
ASAlex Sher
Alex Sher
RTRachel Todd
Rachel Todd
DSDan Shilo
Dan Shilo
KGKirema I. Garcia-Reyes
Kirema I. Garcia-Reyes
VBVivian L. Bishay
Vivian L. Bishay
EKEdward Kim
Edward Kim

28 January 2023 in Clinical Imaging
Verified
Journal Article
Closed access
AMAriana C. Mills
Ariana C. Mills
DGDaryl T. Goldman
Daryl T. Goldman
BMBrett Marinelli
Brett Marinelli
JSJay Sanghvi
Jay Sanghvi
KGKirema Garcia-Reyes
Kirema Garcia-Reyes
VBVivian Lee Lee Bishay
Vivian Lee Lee Bishay

28 May 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
BOBurak Berksu Ozkara
Burak Berksu Ozkara
DBDavid Bamshad
David Bamshad
RGRamita Gowda
Ramita Gowda
MKMert Karabacak
Mert Karabacak
VBVivian Lee Lee Bishay
Vivian Lee Lee Bishay
AFAaron Fischman
Aaron Fischman
Background/Objectives: Prostatic artery embolization (PAE) has been increasingly recognized, especially with recent progress in embolization techniques for the management of lower urinary tract symptoms due to benign prostatic hyperplasia. Nevertheless, a proportion of patients undergoing PAE fail to demonstrate clinical improvement. Machine learning models have the potential to provide valuable prognostic insights for patients undergoing PAE. Methods: A retrospective cohort study was performed utilizing a modified prior-data fitted network architecture to predict short-term (7 weeks) favorable outcomes, defined as a reduction greater than 9 points in the International Prostate Symptom Score (IPSS), in patients who underwent PAE with nBCA glue. Patients were stratified into two groups based on the median IPSS reduction value, and a binary classification model was developed to predict the outcome of interest. The model was developed using clinical tabular data, including both pre-procedural and intra-procedural variables. SHapley Additive ExPlanations (SHAP) were used to uncover the relative importance of features. Results: The final cohort included 109 patients. The model achieved an accuracy of 0.676, an MCC of 0.363, a precision of 0.666, a recall of 0.856, an F1-score of 0.731, and a Brier score of 0.203, with an AUPRC of 0.851 and an AUROC of 0.821. SHAP analysis identified pre-PAE IPSS, prior therapy, right embolization volume, preoperative quality of life, and age as the top five most influential features. Conclusions: Our model showed promising discrimination and calibration in predicting early outcomes of PAE with nBCA glue, highlighting the potential of precision medicine to deliver interpretable, individualized risk assessments.

3 October 2026 in Journal of Vascular and Interventional Radiology
Verified
Journal Article
Closed access
AMAriana C. Mills
Ariana C. Mills
RPRico Pesce
Rico Pesce
RPRahul Patel
Rahul Patel
EKEdward Kim
Edward Kim
AFAaron Fischman
Aaron Fischman
RLRobert Lookstein
Robert Lookstein